Page last updated: 2024-08-18

lactobionic acid and Experimental Mammary Neoplasms

lactobionic acid has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanchard, H; Collins, PM; Darren Grice, I; Gabutero, E; Ito, K; Leffler, H; Low, P; Nilsson, UJ; Ralph, SJ; Scott, SA; Stannard, KA; Sullivan, EM	1

Other Studies

1 other study(ies) available for lactobionic acid and Experimental Mammary Neoplasms

Article	Year
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer letters, 2010, Dec-28, Volume: 299, Issue:2 Topics: Animals; Blotting, Western; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Cytotoxicity, Immunologic; Disaccharides; Female; Galectin 1; Galectin 3; Galectins; Humans; Immunity; Immunotherapy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Models, Molecular; Protein Binding; Thiogalactosides; Tumor Burden	2010

Article

Year

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.

Cancer letters, 2010, Dec-28, Volume: 299, Issue:2

Topics: Animals; Blotting, Western; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Cytotoxicity, Immunologic; Disaccharides; Female; Galectin 1; Galectin 3; Galectins; Humans; Immunity; Immunotherapy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Models, Molecular; Protein Binding; Thiogalactosides; Tumor Burden

2010